ArticleThe oncologist2025

Identifying predictors of overall survival among patients with TMB-low metastatic cancer treated with immune checkpoint inhibitors.

Camila Braganca Xavier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.